Authors:
Pucci, S
Mazzarelli, P
Rabitti, C
Giai, M
Gallucci, M
Flammia, G
Alcini, A
Altomare, V
Fazio, VM
Citation: S. Pucci et al., Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies, ONCOGENE, 20(6), 2001, pp. 739-747
Authors:
Boccardo, F
Rubagotti, A
Amoroso, D
Mesiti, M
Romeo, D
Sismondi, P
Giai, M
Genta, F
Pacini, P
Distante, V
Bolognesi, A
Aldrighetii, D
Farris, A
Citation: F. Boccardo et al., Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial, J CL ONCOL, 18(14), 2000, pp. 2718-2727
Authors:
Casalegno, PS
Sandrucci, S
Bello, M
Durando, A
Danese, S
Silvestro, L
Pellerito, R
Testori, O
Roagna, R
Giai, M
Giani, R
Bussone, R
Favero, A
Bisi, G
Massobrio, M
Giardina, G
Mussa, GC
Sismondi, P
Mussa, A
Citation: Ps. Casalegno et al., Sentinel lymph node and breast cancer staging: Final results of the Turin multicenter study, TUMORI, 86(4), 2000, pp. 300-303
Authors:
Van Dalen, A
Favier, J
Baumgartner, L
Hasholzner, U
De Bruijn, H
Dobbler, D
Dombi, VH
Fink, D
Giai, M
Mcging, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Bowman, A
Einarsson, R
Citation: A. Van Dalen et al., Serum levels of CA 125 and TPS during treatment of ovarian cancer, ANTICANC R, 20(6D), 2000, pp. 5107-5108
Authors:
Bharaj, B
Scorilas, A
Diamandis, EP
Giai, M
Levesque, MA
Sutherland, DJA
Hoffman, BR
Citation: B. Bharaj et al., Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter, BREAST CANC, 61(2), 2000, pp. 111-119
Authors:
Yu, H
Bharaj, B
Vassilikos, EJK
Giai, M
Diamandis, EP
Citation: H. Yu et al., Shorter CAG repeat length in the androgen receptor gene is associated withmore aggressive forms of breast cancer, BREAST CANC, 59(2), 2000, pp. 153-161
Authors:
van Dalen, A
Favier, J
Burges, A
Hasholzner, U
de Bruijn, HWA
Dobler-Girdziunaite, D
Dombi, VH
Fink, D
Giai, M
McGing, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Bowman, A
Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients, GYNECOL ONC, 79(3), 2000, pp. 444-450
Authors:
Angelopoulou, K
Yu, H
Bharaj, B
Giai, M
Diamandis, EP
Citation: K. Angelopoulou et al., p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer, CLIN BIOCH, 33(1), 2000, pp. 53-62
Authors:
Scorilas, A
Diamandis, EP
Levesque, MA
Papanastasiou-Diamandi, A
Khosravi, MJ
Giai, M
Ponzone, R
Roagna, R
Sismondi, P
Lopez-Otin, C
Citation: A. Scorilas et al., Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: An independent favorable prognostic factor in node-positive patients, CLIN CANC R, 5(7), 1999, pp. 1778-1785
Authors:
Borchert, GH
Yu, H
Tomlinson, G
Giai, M
Roagna, R
Ponzone, R
Sgro, L
Diamandis, EP
Citation: Gh. Borchert et al., Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease, J CL LAB AN, 13(2), 1999, pp. 75-81
Authors:
Van Dalen, A
Favier, J
Baumgartner, L
Hasholzner, U
De Bruijn, H
Dobbler, D
Dombi, VH
Fink, D
Giai, M
McGing, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients, ANTICANC R, 19(4A), 1999, pp. 2523-2526
Authors:
Borchert, GH
Melegos, DN
Yu, H
Giai, M
Roagna, R
Ponzone, R
Sgro, L
Diamandis, EP
Citation: Gh. Borchert et al., Quantification of pepsinogen C and prostaglandin D synthase in breast cystfluid and their potential utility for cyst type classification, CLIN BIOCH, 32(1), 1999, pp. 39-44